Y A Elsayed
Overview
Explore the profile of Y A Elsayed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, et al.
Ann Oncol
. 2017 Apr;
28(7):1436-1447.
PMID: 28379322
In recent years, the number of approved and investigational agents that can be safely administered for the treatment of lymphoma patients for a prolonged period of time has substantially increased....
2.
Gore L, Rivera E, Basche M, Moulder-Thompson S, Li J, Eppers S, et al.
Invest New Drugs
. 2011 Sep;
30(5):1942-9.
PMID: 21931969
Background: To determine the maximum tolerated dose (MTD), safety and pharmacokinetics of trabectedin with capecitabine in patients with advanced malignancies. Design: In this Phase I, open-label, dose-finding study, patients refractory...
3.
Elsayed Y, Sausville E
Oncologist
. 2001 Dec;
6(6):517-37.
PMID: 11743214
Empirical approaches to discovery of anticancer drugs and cancer treatment have made limited progress in the cure of cancer in the last several decades. Recent advances in technology and expanded...
4.
Elsayed Y, Nakagawa K, Kamikubo Y, Enjyoji K, Kato H, Sueishi K
Am J Clin Pathol
. 1996 Nov;
106(5):574-83.
PMID: 8929465
Tissue factor pathway inhibitor (TFPI) plays a key role in modulating tissue factor-dependent blood coagulation. This study was done to determine not only the inhibitory effects of recombinant human TFPI...
5.
Kato K, Elsayed Y, Namoto M, Nakagawa K, Sueishi K
Thromb Res
. 1996 May;
82(4):335-47.
PMID: 8743729
Tissue factor (TF) is an initiation cofactor of the extrinsic pathway of coagulation. Although the overexpression of TF antigen and mRNA have been previously demonstrated in atherosclerotic lesions using both...
6.
Sueishi K, Ichikawa K, Nakagawa K, Kato K, Elsayed Y, Namoto M
Ann N Y Acad Sci
. 1995 Jan;
748:185-92; discussion 192-3.
PMID: 7695164
TF protein was overexpressed by macrophages and smooth muscle cells and deposited in the extracellular matrix of atheroclerotic intimas. TF activity was also enhanced in the atherosclerotic intima, probably resulting...
7.
Elsayed Y, Nakagawa K, Ichikawa K, Ohkawara S, Sueishi K
Pathobiology
. 1995 Jan;
63(6):328-40.
PMID: 8738472
Thrombus formation and the sequential expression of tissue factor (TF), interleukin-1 beta (IL-1 beta) and interleukin-1 receptor antagonist (IL-1 ra) in several organs were examined immunohistochemically and morphometrically in a...